{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:22:06Z","timestamp":1783689726302,"version":"3.55.0"},"reference-count":103,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Sjogren\u2019s syndrome (SS) is a frequent entity with a broad symptomatology spectrum, mainly affecting the salivary and lachrymal glands. The disease also affects the musculoskeletal system targeting bones, specific joints, muscles, and the peripheral nerve system. Disease related clinical manifestations canhave an accumulative impact, as the syndrome is commonly associated with other rheumatic diseases. A literature review was performed with the aim to assess the in-depth association of Sjogren\u2019s syndrome and its treatment agents with the musculoskeletal system and further investigate its potential relevance with common orthopedic postoperative complications.<\/jats:p>","DOI":"10.3390\/jcm10081574","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T11:58:45Z","timestamp":1617883125000},"page":"1574","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Musculoskeletal Manifestations in Sjogren\u2019s Syndrome: An Orthopedic Point of View"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-3641","authenticated-orcid":false,"given":"Meletios","family":"Rozis","sequence":"first","affiliation":[{"name":"3rd Department of Orhopaedic Surgery, School of Medicine, National and Kapodistrian University of Athens, KAT Hospital, 145 61 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vlamis","sequence":"additional","affiliation":[{"name":"3rd Department of Orhopaedic Surgery, School of Medicine, National and Kapodistrian University of Athens, KAT Hospital, 145 61 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2428-5250","authenticated-orcid":false,"given":"Elias","family":"Vasiliadis","sequence":"additional","affiliation":[{"name":"3rd Department of Orhopaedic Surgery, School of Medicine, National and Kapodistrian University of Athens, KAT Hospital, 145 61 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio","family":"Mavragani","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, 157 72 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Pneumaticos","sequence":"additional","affiliation":[{"name":"3rd Department of Orhopaedic Surgery, School of Medicine, National and Kapodistrian University of Athens, KAT Hospital, 145 61 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios Stergios","family":"Evangelopoulos","sequence":"additional","affiliation":[{"name":"3rd Department of Orhopaedic Surgery, School of Medicine, National and Kapodistrian University of Athens, KAT Hospital, 145 61 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"ref_1","first-page":"584","article-title":"Sjogren\u2019s syndrome: Review of the aetiology, Pathophysiology & Potential therapeutic interventions","volume":"9","author":"Nair","year":"2017","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1503\/cmaj.122037","article-title":"Sj\u00f6gren syndrome","volume":"186","author":"Mavragani","year":"2014","journal-title":"CMAJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/acr.21610","article-title":"Primary Sjogren\u2019s syndrome as a systemic disease: A study of participants enrolled in an international Sjogren\u2019s syndrome registry","volume":"64","author":"Malladi","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part, I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Soyfoo, M.S., Chivasso, C., Perret, J., and Delporte, C. (2018). Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjogren\u2019s Syndrome. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113392"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7150\/ijms.17718","article-title":"Reviewing primary Sjogren\u2019s syndrome: Beyond the dryness\u2014From pathophysiology to diagnosis and treatment","volume":"14","author":"Both","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.001","article-title":"Sj\u00f6gren\u2019s syndrome: A forty-year scientific journey","volume":"51","author":"Moutsopoulos","year":"2014","journal-title":"J.Autoimmun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/annrheumdis-2019-216588","article-title":"Salivary gland epithelial cells from patients with Sj\u00f6gren\u2019s syndrome induce B-lymphocyte survival and activation","volume":"79","author":"Pascaud","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3389\/fgene.2019.01104","article-title":"Epigenetic Regulation in the Pathogenesis of Sjogren Syndrome and Rheumatoid Arthritis","volume":"10","author":"Pallardo","year":"2019","journal-title":"Front Genet."},{"key":"ref_10","first-page":"185","article-title":"Type I interferon signature in Sj\u00f6gren\u2019s syndrome: Pathophysiological and clinical implications","volume":"37","author":"Marketos","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bodewes, I.L.A., Bj\u00f6rk, A., Versnel, M.A., and Wahren-Herlenius, M. (2019). Innate immunity and interferons in the pathogenesis of Sj\u00f6gren\u2019s syndrome. Rheumatology, 360.","DOI":"10.1093\/rheumatology\/key360"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncprheum0173","article-title":"Mechanisms of Disease: Primary Sjogren\u2019s syndrome and the type I interferon system","volume":"2","author":"Nordmark","year":"2006","journal-title":"Nat. Clin.Pract. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/eos.12536","article-title":"Current concepts on Sjogren\u2019s syndrome\u2014Classification criteria and biomarkers","volume":"126","author":"Jonsson","year":"2018","journal-title":"Eur. J. Oral Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren\u2019s syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","article-title":"Treatment of primary Sjogren syndrome","volume":"12","author":"Saraux","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.31138\/mjr.29.4.224","article-title":"Study of the incidence of osteoporosis in patients with Sjogren\u2019s syndrome (pSS) and investigation of activation of the RANKL \/RANK and osteoprotegerin (OPG) system","volume":"29","author":"Skarlis","year":"2018","journal-title":"Mediterr. J. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3346\/jkms.2003.18.4.606","article-title":"Sjogren\u2019s syndrome presenting as remitting seronegative symmetric synovitis with pitting edema (RS3PE)","volume":"18","author":"Choi","year":"2003","journal-title":"J. Korean Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/rheumatology\/kez269","article-title":"Risk of Wnt\/beta-catenin signalling pathway gene polymorphisms in primary Sjogren\u2019s syndrome","volume":"59","year":"2020","journal-title":"Rheumatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13075-015-0613-6","article-title":"Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren\u2019s syndrome: Prevalence, clinical and laboratory associations","volume":"17","author":"Gravani","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/rheumatology\/kew332","article-title":"Cortical bone density and thickness alterations by high-resolution peripheral quantitative computed tomography: Association with vertebral fractures in primary Sjogren\u2019s syndrome","volume":"55","author":"Pasoto","year":"2016","journal-title":"Rheumatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00296-020-04615-3","article-title":"Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjogren syndrome","volume":"40","author":"Andreu","year":"2020","journal-title":"Rheumatol. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00393-018-0510-x","article-title":"Hammer, M.Osteomalacia-Clinical aspects, diagnostics and treatment","volume":"77","author":"Tiefenbach","year":"2018","journal-title":"Z. Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10067-017-3762-y","article-title":"Tubulointerstitial nephritis-induced hypophosphatemicosteomalacia in Sjogren\u2019s syndrome: A case report and review of the literature","volume":"37","author":"Geng","year":"2018","journal-title":"Clin.Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archinte.164.8.905","article-title":"Renal tubular acidosis, Sjogren syndrome, and bone disease","volume":"164","author":"Fulop","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.12659\/AJCR.907503","article-title":"Sjogren\u2019s Syndrome Associated with Fanconi\u2019s Syndrome and Osteomalacia","volume":"19","author":"Gutierrez","year":"2018","journal-title":"Am. J. Case Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4103\/1319-2442.139944","article-title":"Osteomalacia complicating renal tubular acidosis in association with Sjogren\u2019s syndrome","volume":"25","author":"Fatma","year":"2014","journal-title":"Saudi. J. Kidney Dis. Transpl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e6493","DOI":"10.1097\/MD.0000000000006493","article-title":"Adult-onset hypophosphatemicosteomalacia associated with Sjogren syndrome: Clinical case report","volume":"96","author":"Shen","year":"2017","journal-title":"Medicine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13730-012-0027-0","article-title":"Osteomalacia secondary to renal tubular acidosis due to Sjogren\u2019s syndrome: A case report and review of the literature","volume":"1","author":"Nagae","year":"2012","journal-title":"CEN Case Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/rheumatology\/keu401","article-title":"Prevalence of distal renal tubular acidosis in primary Sjogren\u2019s syndrome","volume":"54","author":"Both","year":"2015","journal-title":"Rheumatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/rheumatology\/38.11.1113","article-title":"The occurrence of renal involvement in primary Sjogren\u2019s syndrome: A study of 78 patients","volume":"38","author":"Pertovaara","year":"1999","journal-title":"Rheumatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4068\/cmj.2018.54.1.78","article-title":"HypophosphatemicOsteomalacia with Multiple Bone Fractures: ADV-Induced Fanconi\u2019s Syndrome","volume":"54","author":"Kim","year":"2018","journal-title":"Chonnam. Med. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00223-016-0112-z","article-title":"Bone Mineral Density in Sjogren Syndrome Patients with and Without Distal Renal Tubular Acidosis","volume":"98","author":"Both","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3899\/jrheum.150841","article-title":"Increased Frequency of Hand Osteoarthritis in Patients with Primary Sjogren Syndrome Compared with Systemic Lupus Erythematosus","volume":"43","author":"Aksoy","year":"2016","journal-title":"J. Rheumatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sjogren syndrome in Spain: Clinical and immunologic expression in 1010 patients","volume":"87","author":"Solans","year":"2008","journal-title":"Medicine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s10067-020-04983-y","article-title":"Characterizing hand and wrist ultrasound pattern in primary Sjogren\u2019s syndrome: A case-control study","volume":"39","author":"Guedes","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-0038-1639473","article-title":"Musculoskeletal Manifestations of Non-RA Connective Tissue Diseases: Scleroderma, Systemic Lupus Erythematosus, Still\u2019s Disease, Dermatomyositis\/Polymyositis, Sjogren\u2019s Syndrome, and Mixed Connective Tissue Disease","volume":"22","author":"Jacques","year":"2018","journal-title":"Semin. Musculoskelet. Radiol."},{"key":"ref_37","first-page":"747","article-title":"Ultrasound imaging for the rheumatologist. XXIII. Sonographic evaluation of hand joint involvement in primary Sjogren\u2019s syndrome","volume":"27","author":"Riente","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.autrev.2018.06.015","article-title":"Arthritis in primary Sjogren\u2019s syndrome: Characteristics, outcome and treatment from French multicenter retrospective study","volume":"18","author":"Mirouse","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_39","first-page":"88","article-title":"A study of the arthritis pattern in primary Sjogren\u2019s syndrome","volume":"25","author":"Haga","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/rheumatology\/32.7.609","article-title":"The arthropathy of Sjogren\u2019s syndrome","volume":"32","author":"Pease","year":"1993","journal-title":"Br. J. Rheumatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/rheumatology\/keq047","article-title":"Articular manifestations in primary Sjogren\u2019s syndrome: Clinical significance and prognosis of 188 patients","volume":"49","author":"Fauchais","year":"2010","journal-title":"Rheumatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e000066","DOI":"10.1136\/rmdopen-2015-000066","article-title":"ACPA-positive primary Sjogren\u2019s syndrome: True primary or rheumatoid arthritis-associated Sjogren\u2019s syndrome?","volume":"1","author":"Payet","year":"2015","journal-title":"RMD Open"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00296-012-2572-4","article-title":"Follow-up of primary Sjogren\u2019s syndrome patients presenting positive anti-cyclic citrullinated peptides antibody","volume":"33","author":"Ryu","year":"2013","journal-title":"Rheumatol. Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/ar2420","article-title":"Anti-cyclic citrullinated peptide antibodies in primary Sjogren syndrome may be associated with non-erosive synovitis","volume":"10","author":"Atzeni","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/03009742.2018.1469164","article-title":"Anti-citrullinated protein antibodies and arthritis in Sjogren\u2019s syndrome: A systematic review and meta-analysis","volume":"48","author":"Anaya","year":"2019","journal-title":"Scand. J. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.berh.2015.05.002","article-title":"Pain in primary Sjogren\u2019s syndrome","volume":"29","author":"Vitali","year":"2015","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Singh, J.A., and Cleveland, J.D. (2020). Sjogren\u2019s syndrome is associated with higher rate of non-home discharge after primary hip arthroplasty and higher transfusion rates after primary hip or knee arthroplasty: A U.S. cohort study. BMC Musculoskelet. Disord., 21.","DOI":"10.1186\/s12891-020-03514-9"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.autrev.2018.09.004","article-title":"Novel Sj\u00f6gren\u2019s autoantibodies found in fibromy- algia patients with sicca and\/or xerostomia","volume":"18","author":"Applbaum","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3904\/kjim.2016.276","article-title":"Clinical significance of anti-dense fine speck- led 70 antibody in patients with fibromyalgia","volume":"34","author":"Jeong","year":"2019","journal-title":"Korean J. Intern. Med."},{"key":"ref_50","first-page":"28","article-title":"SJOGRENSER Study Group of the Spanish Society of Rheumatology. Fibromyalgia prevalence and associated factors in primary Sj\u00f6gren\u2019s syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER)","volume":"35","author":"Corominas","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_51","first-page":"1","article-title":"Ankylosing spondylitis coexists with rheumatoid arthritis and Sjogren\u2019s syndrome: A case report with literature review","volume":"168","author":"Zhao","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s13075-014-0489-x","article-title":"Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sjogren\u2019s syndrome uncovered through gene expression meta-analysis","volume":"16","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6728694","DOI":"10.1155\/2019\/6728694","article-title":"TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients","volume":"2019","author":"Ciccacci","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s10067-020-05004-8","article-title":"Prevalence of Sjogren\u2019s syndrome associated with rheumatoid arthritis in the USA: An observational study from the Corrona registry","volume":"39","author":"Harrold","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1038\/s41598-018-24279-1","article-title":"Clinical characteristics and risk factors for overlapping rheumatoid arthritis and Sjogren\u2019s syndrome","volume":"8","author":"Yang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/rheumatology\/kes374","article-title":"Characteristics of Sjogren\u2019s syndrome in rheumatoid arthritis","volume":"52","author":"He","year":"2013","journal-title":"Rheumatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/030097402760375197","article-title":"Knee joint synovitis in Sjogren\u2019s syndrome. Sonographic study","volume":"31","author":"Iagnocco","year":"2002","journal-title":"Scand. J. Rheumatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/14397595.2018.1530849","article-title":"The findings of musculoskeletal ultrasonography on primary Sjogren\u2019s syndrome patients in childhood with articular manifestations and the impact of anti-cyclic citrullinated peptide antibody","volume":"29","author":"Shabana","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/03009748609092600","article-title":"Hand radiographic changes in patients with primary and secondary Sjogren\u2019s syndrome","volume":"15","author":"Tsampoulas","year":"1986","journal-title":"Scand. J. Rheumatol."},{"key":"ref_60","first-page":"640265","article-title":"Joint involvement in primary Sjogren\u2019s syndrome: An ultrasound \u201ctarget area approach to arthritis\u201d","volume":"2013","author":"Hofmann","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"ref_61","first-page":"44","article-title":"Osteoporosis in patients with subclinical hypothyroidism treated with thyroid hormone","volume":"8","author":"Lopez","year":"2011","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.arth.2015.10.028","article-title":"Increased Risk of Periprosthetic Joint Infections in Patients with Hypothyroidism Undergoing Total Joint Arthroplasty","volume":"31","author":"Tan","year":"2016","journal-title":"J. Arthroplasty"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.arth.2017.10.053","article-title":"Hypothyroidism Increases 90-Day Complications and Costs Following Primary Total Knee Arthroplasty","volume":"33","author":"Buller","year":"2018","journal-title":"J. Arthroplasty"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/BF03350206","article-title":"Development of thyroid disease in patients with primary and secondary Sjogren\u2019s syndrome","volume":"11","author":"Loviselli","year":"1988","journal-title":"J. Endocrinol. Investig."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/ard.2003.010058","article-title":"Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren\u2019s syndrome: A case-control study","volume":"63","author":"Tunc","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fendo.2018.00121","article-title":"The Association of Sjogren Syndrome and Autoimmune Thyroid Disorders","volume":"9","author":"Baldini","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF03344036","article-title":"Thyroid hormone autoantibodies in primary Sjogren syndrome and rheumatoid arthritis are more prevalent than in autoimmune thyroid disease, becoming progressively more frequent in these diseases","volume":"25","author":"Ruggeri","year":"2002","journal-title":"J. Endocrinol. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e6737","DOI":"10.7717\/peerj.6737","article-title":"Increased risk of thyroid disease in patients with Sjogren\u2019s syndrome: A systematic review and meta-analysis","volume":"7","author":"Sun","year":"2019","journal-title":"PeerJ"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/rheumatology\/32.1.36","article-title":"Thyroid disease and other autoimmune phenomena in a family study of primary Sjogren\u2019s syndrome","volume":"32","author":"Foster","year":"1993","journal-title":"Br. J. Rheumatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12016-018-8709-9","article-title":"Sjogren\u2019s Syndrome and Autoimmune Thyroid Disease: Two Sides of the Same Coin","volume":"56","author":"Anaya","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_71","first-page":"e010003","article-title":"Splinting for carpal tunnel syndrome","volume":"7","author":"Page","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"446","DOI":"10.12659\/MSM.892462","article-title":"Effect of heat, cold, and pressure on the transverse carpal ligament and median nerve: A pilot study","volume":"21","author":"Laymon","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.lpm.2012.06.002","article-title":"Central and peripheral neurological complications of primary Sjogren\u2019s syndrome","volume":"41","author":"Fauchais","year":"2012","journal-title":"Presse Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jnnp.2010.222109","article-title":"Peripheral neuropathies in Sjogren syndrome: A new reappraisal","volume":"82","author":"Pavlakis","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archneur.63.11.1612","article-title":"Peripheral neuropathy in primary sjogren syndrome: A population-based study","volume":"63","author":"Goransson","year":"2006","journal-title":"Arch. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/jnnp.57.8.983","article-title":"Peripheral neuropathy associated with primary Sjogren\u2019s syndrome","volume":"57","author":"Gemignani","year":"1994","journal-title":"J. Neurol.Neurosurg. Psychiatry"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sjogren syndrome: A study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine"},{"key":"ref_78","first-page":"645967","article-title":"Neurological Disorders in Primary Sjogren\u2019s Syndrome","volume":"2012","author":"Tobon","year":"2012","journal-title":"Autoimmune Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e000179","DOI":"10.1136\/rmdopen-2015-000179","article-title":"Epidemiology of neurological manifestations in Sjogren\u2019s syndrome: Data from the French ASSESS Cohort","volume":"2","author":"Guellec","year":"2016","journal-title":"RMD Open"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2169\/internalmedicine.41.142","article-title":"Motor dominant neuropathy in Sjogren\u2019s syndrome: Report of two cases","volume":"41","author":"Mochizuki","year":"2002","journal-title":"Intern. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e3632","DOI":"10.1097\/MD.0000000000003632","article-title":"Sjogren Sensory Neuronopathy (Sjogren Ganglionopathy): Long-Term Outcome and Treatment Response in a Series of 13 Cases","volume":"95","author":"Pereira","year":"2016","journal-title":"Medicine"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5114\/reum.2018.75521","article-title":"Neurological manifestations of primary Sjogren\u2019s syndrome","volume":"56","author":"Maslinska","year":"2018","journal-title":"Reumatologia"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Qin, B., Wang, J., Liang, Y., Yang, Z., and Zhong, R. (2013). The association between TNF-alpha, IL-10 gene polymorphisms and primary Sjogren\u2019s syndrome: A meta-analysis and systemic review. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063401"},{"key":"ref_84","unstructured":"Fox, R.I., Fox, C.M., Gottenberg, J.E., and Dorner, T. (2019). Treatment of Sjogren\u2019s syndrome: Current therapy and future directions. Rheumatology, 142."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","article-title":"New Treatment Guidelines for Sjogren\u2019s Disease","volume":"42","author":"Vivino","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_86","first-page":"354","article-title":"The Diagnosis and Treatment of Sjogren\u2019s Syndrome","volume":"114","author":"Stefanski","year":"2017","journal-title":"Dtsch.Arztebl. Int."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","article-title":"Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.oooo.2020.06.011","article-title":"Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19","volume":"131","author":"Hussein","year":"2021","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0001-7310(07)70127-8","article-title":"Corticosteroids and osteoporosis","volume":"98","author":"Gantes","year":"2007","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/acr.22968","article-title":"Treatment Guidelines for Rheumatologic Manifestations of Sjogren\u2019s Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal","volume":"69","author":"Carsons","year":"2017","journal-title":"Pain Arthritis Care Res."},{"key":"ref_91","first-page":"149","article-title":"Prednisone and piroxicam for treatment of primary Sjogren\u2019s syndrome","volume":"11","author":"Fox","year":"1993","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.2010.1014","article-title":"Treatment of primary Sjogren syndrome: A systematic review","volume":"304","author":"Tzioufas","year":"2010","journal-title":"JAMA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2147\/CIA.S85225","article-title":"Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats","volume":"10","author":"Liu","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/14740338.2017.1310839","article-title":"Effect of methotrexate on bone and wound healing","volume":"16","author":"Pountos","year":"2017","journal-title":"Expert Opin Drug Saf."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Lee, A.M., Shandala, T., Soo, P.P., Su, Y.W., King, T.J., Chen, K.M., Howe, P.R., and Xian, C.J. (2017). Effects of Resveratrol Supplementation on Methotrexate Chemotherapy-Induced Bone Loss. Nutrients, 9.","DOI":"10.3390\/nu9030255"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00774-003-0489-4","article-title":"The active metabolite of leflunomide, A771726, inhibits both the generation of and the bone-resorbing activity of osteoclasts by acting directly on cells of the osteoclast lineage","volume":"22","author":"Kobayashi","year":"2004","journal-title":"J. Bone Miner. Metab."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clim.2017.05.002","article-title":"The value of rituximab treatment in primary Sjogren\u2019s syndrome","volume":"182","author":"Verstappen","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","article-title":"Efficacy of rituximab in systemic manifestations of primary Sjogren\u2019s syndrome: Results in 78 patients of the AutoImmune and Rituximab registry","volume":"72","author":"Gottenberg","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/ar3337","article-title":"Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: Experience from a national registry (GRAID)","volume":"13","author":"Tony","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/1756-185X.13596","article-title":"Infection risks of rituximab versus non-rituximab treatment for rheumatoid arthritis: A systematic review and meta-analysis","volume":"22","author":"Shi","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3109\/14397595.2016.1158773","article-title":"Effectiveness of abatacept for patients with Sjogren\u2019s syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjogren\u2019s syndrome Endocrinopathy) trial","volume":"26","author":"Tsuboi","year":"2016","journal-title":"Mod. Rheumatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10067-019-04724-w","article-title":"Effectiveness and safety of abatacept for the treatment of patients with primary Sjogren\u2019s syndrome","volume":"39","author":"Machado","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-017-3922-z","article-title":"Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study","volume":"38","author":"Tada","year":"2018","journal-title":"Rheumatol. Int."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/8\/1574\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:58:55Z","timestamp":1760363935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/8\/1574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":103,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["jcm10081574"],"URL":"https:\/\/doi.org\/10.3390\/jcm10081574","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]}}}